APA (7th ed.) Citation

BA, S., E, C. C., J, B., JI, C., PE, C., L, G. G., . . . P, L. (2023). Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs. Multiple sclerosis and related disorders, 77, 104840. https://doi.org/10.1016/j.msard.2023.104840

Chicago Style (17th ed.) Citation

BA, Silva, et al. "Latin American Consensus Recommendations on the Risk of Infections in People with Multiple Sclerosis Treated with Disease Modifying Drugs." Multiple Sclerosis and Related Disorders 77 (2023): 104840. https://doi.org/10.1016/j.msard.2023.104840.

MLA (9th ed.) Citation

BA, Silva, et al. "Latin American Consensus Recommendations on the Risk of Infections in People with Multiple Sclerosis Treated with Disease Modifying Drugs." Multiple Sclerosis and Related Disorders, vol. 77, 2023, p. 104840, https://doi.org/10.1016/j.msard.2023.104840.